Federal award
ROCHE DIAGNOSTICS CORPORATION
W81K0020C0006
Contract
Obligated and Ceiling
- Obligated (net)
- $6,996,763.31
- Ceiling (potential value, not spending)
- $7,416,508.36
- Current value
- $6,996,763.31
- Gross positive obligations
- $10,108,589.83
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ROCHE HOLDING AG · WJHDT127L353
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0020C0006
- Award type code
- D
- Actions
- 22 · Jul 15, 2020 to Sep 19, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History22
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 19, 2025 | FY2025 | P00021 | C | −$142,380.32 | — |
| Mar 21, 2025 | FY2025 | P00020 | C | −$147,113.75 | — |
| Nov 13, 2024 | FY2025 | P00019 | C | $1,708,563.84 | — |
| Sep 20, 2024 | FY2024 | P00018 | C | $126,034.17 | — |
| Sep 3, 2024 | FY2024 | P00017 | C | −$461,872.14 | — |
| Aug 27, 2024 | FY2024 | P00016 | G | $0.00 | — |
| Apr 4, 2024 | FY2024 | P00015 | C | −$399,757.19 | — |
| Oct 26, 2023 | FY2024 | P00014 | C | $2,026,960.87 | — |
| Sep 6, 2023 | FY2023 | P00013 | C | −$360,703.12 | — |
| Jul 3, 2023 | FY2023 | P00012 | G | $0.00 | — |
| May 24, 2023 | FY2023 | P00011 | M | $0.00 | — |
| Oct 19, 2022 | FY2023 | P00010 | C | $1,930,438.92 | — |
| Jul 13, 2022 | FY2022 | P00009 | M | $400,000.00 | — |
| May 6, 2022 | FY2022 | P00008 | G | $0.00 | — |
| Apr 11, 2022 | FY2022 | P00007 | C | −$600,000.00 | — |
| Oct 18, 2021 | FY2022 | P00006 | C | $1,838,513.27 | — |
| Sep 9, 2021 | FY2021 | P00005 | C | $180,000.00 | — |
| May 6, 2021 | FY2021 | P00004 | C | −$1,000,000.00 | — |
| Apr 26, 2021 | FY2021 | P00003 | G | $0.00 | — |
| Oct 26, 2020 | FY2021 | P00002 | C | $1,750,965.01 | — |
| Aug 17, 2020 | FY2020 | P00001 | G | $0.00 | — |
| Jul 15, 2020 | FY2020 | 0 | — | $147,113.75 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.